🔍 Are you grappling with inefficiencies in your Bispecific Antibody (BsAB) discovery process? 🧪 Is the frustration of running numerous microtiter plates, only to struggle in identifying that optimal lead molecule, slowing you down and draining your resources?

Look no further! Aureka Bio has your solution. 🚀

We proudly offer pharmaceutical and biotech clients a cutting-edge, high-throughput, single-cell- and combinatorial library-based BsAB functional screening solution. This technology empowers you to explore a vast array of variables and combinations, ranging from 1,000s to 100,000s of variants, all in a single experiment.

Our innovative approach is versatile, catering to the discovery of a wide spectrum of bispecific/multispecific, dual- or proximity-targeting modalities. Whether you're working on T-cell engagers like BiTEs, TCR mimics, soluble TCRs, bispecific/biparatopic ADCs, protein degraders and PROTABs, cytokine mimics, fusion proteins, or multi-subunit membrane receptor modulators, Aureka Bio has you covered!

Ready to optimize your BsAB discovery process and unlock new possibilities? 💡

Contact us today at contact@aurekabio.com for inquiries, and take the first step towards transformative BsAB discovery.

Don't miss out! 📥 You can also download a free Application Note to get a deeper insight into our solution: Download Here